Fingerprint
Dive into the research topics of 'Reduction in cardiovascular events with Atorvastatin in 2,532 patients with type 2 diabetes: Anglo Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically